ChemicalBook >> CAS DataBase List >>6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide

6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide

CAS No.
74115-08-5
Chemical Name:
6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide
Synonyms
J2.054.792H;SKF 83822 hydrobromi;SKF 83822 HYDROBROMIDE;1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propen-1-yl)-;6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide
CBNumber:
CB9106211
Molecular Formula:
C20H22ClNO2
Molecular Weight:
343.85
MDL Number:
MFCD07773055
MOL File:
74115-08-5.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-09-12 18:55:54

6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide Properties

storage temp. Store at RT
form Solid
color Off-white to gray
FDA UNII 661JNG0144

SAFETY

Risk and Safety Statements

6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth ZCA11508 SKF 83822 74115-08-5 50mg $932 2026-06-05 Buy
Biosynth ZCA11508 SKF 83822 74115-08-5 100mg $1490 2026-06-05 Buy
ChemScene CS-0066723 SKF 83822 98.01% 74115-08-5 5mg $271 2026-06-04 Buy
ChemScene CS-0066723 SKF 83822 98.01% 74115-08-5 10mg $412 2026-06-04 Buy
ChemScene CS-0066723 SKF 83822 98.01% 74115-08-5 25mg $812 2026-06-04 Buy
Product number Packaging Price Buy
ZCA11508 50mg $932 Buy
ZCA11508 100mg $1490 Buy
CS-0066723 5mg $271 Buy
CS-0066723 10mg $412 Buy
CS-0066723 25mg $812 Buy

6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide Chemical Properties,Uses,Production

Uses

SKF 83822 is a dopamine D1-like receptor agonist.

Definition

ChEBI: N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol is a benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a 3-methylphenyl substituent at position 1, an allyl substituent at position 3, a chloro substituent at position 6 and two hydroxy substituents at positions 7 and 8. High affinity, selective dopamine D1-like receptor agonist. Ki values are 3.2, 3.1, 186, 66, 335, 1167, 1251 and 1385 nM at recombinant D1, D5, D2, D3, D4, 5-HT2A, alpha1A and alpha1B receptors respectively. Stimulates adenylyl cyclase (EC50 = 65 nM) but not phosphoinositide hydrolysis. Induces extreme arousal and hyperlocomotion following subcutaneous administration in monkeys. It has a role as a dopamine agonist. It is a benzazepine, a member of catechols, an organochlorine compound and a tertiary amino compound. It is a conjugate acid of a N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+).

Biological Activity

High affinity, selective dopamine D 1 -like receptor agonist. K i values are 3.2, 3.1, 186, 66, 335, 1167, 1251 and 1385 nM at recombinant D 1 , D 5 , D 2 , D 3 , D 4 , 5-HT 2A , α 1A and α 1B receptors respectively. Stimulates adenylyl cyclase (EC 50 = 65 nM) but not phosphoinositide hydrolysis. Induces extreme arousal and hyperlocomotion following subcutaneous administration in monkeys.

in vivo

SKF 83822 (25-100 μg/kg; s.c.; single dose after antagonist) produces a strong rotational response in rat in a dose-dependent manner. And it also stimulates strong expression of the IEG products c-Fos, Fra2, Zif/268 and Arc in the deinnervated striatum[1].
SKF 83822 shows significant effects in a moderate and high dose with 0.25 mg/kg and 0.35 mg/kg, respectively, in monkeys. And it (0.15-0.35 mg/kg; s.c.; single dose) induces locomotion but nor inducing dyskinesia. SKF 83822 results in a state of extreme arousal and locomotor activation without stereotypy[2].

Animal Model:Adult, male Sprague-Dawley derived rats[1]
Dosage:6.25 μg/kg, 25 μg/kg, 50 μg/kg, and 100 μg/kg; with or without 0.5 mg/kg antagonist SCH 23390.
Administration:SC; single dose, 30 min after antagonist treatment.
Result:Produced a strong rotational response at 50 μg/kg which was approximately midway between that produced by the 25 and 100 μg/kg doses in the first experiment.
Could be inhibited by antagonist of dopamine D1 receptor, SCH 23390.

IC 50

Rat D1 Receptor

6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide Preparation Products And Raw materials

Raw materials

Preparation Products

6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide Suppliers

Global( 15)Suppliers
Supplier Tel Email Country ProdList Advantage
3B Pharmachem (Wuhan) International Co.,Ltd. 18930552037 3bsc@sina.com China 15813 69
EMMX Biotechnology LLC 888-539-0666 info@emmx.com United States 8435 60
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
Energy Chemical 021-58432009 400-005-6266 marketing@energy-chemical.com China 44871 58
Shanghai Universal Biotech Co.,Ltd 15921930842 15921930842 yh-wang@univ-bio.com China 25030 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
DAYANG CHEM (HANGZHOU) CO.,LTD +86-88938639 +86-17705817739 info@dycnchem.com China 53799 58
TargetMol Chemicals Inc. 13564774135 marketing@targetmol.com United States 19950 58

View Lastest Price from 6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
SKF-83822 pictures 2026-07-15 SKF-83822
74115-08-5
$766.00-1570.00 10g TargetMol Chemicals Inc.
  • SKF-83822 pictures
  • SKF-83822
    74115-08-5
  • $766.00-1570.00
  • TargetMol Chemicals Inc.
SKF 83822 HYDROBROMIDE 1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propen-1-yl)- SKF 83822 hydrobromi J2.054.792H 6-Chloro-2,3,4,5-tetrahydro-1-(3-methylphenyl)-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide 74115-08-5 C20H22ClNO2HBr